Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease

William J McGeown, Michael F Shanks, Annalena Venneri

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) indicate that the short and long term actions of ChEIs are dissimilar. fMRI studies of the ChEI rivastigmine have focused on its short term action. In this exploratory study the effect of prolonged (20 weeks) rivastigmine treatment on regional brain activity was measured with fMRI in patients with mild AD. Eleven patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. There was an increase in task-related brain activity after treatment with activations more like those of normal healthy elderly. Behaviorally, however, there were no significant differences between baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Variable patient response and drug dynamic/kinetic factors in small patient groups will inevitably bias (either way) the effect size of any relevant drug related changes in activation. Future studies should take drug response into account to provide more insight into the benefits of ChEI drugs at the individual level.
LanguageEnglish
Pages465-476
Number of pages12
JournalNeuropsychiatric Disease and Treatment
Volume4
Issue number2
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Cholinergic Agents
Alzheimer Disease
Rivastigmine
Cholinesterase Inhibitors
Magnetic Resonance Imaging
Pharmaceutical Preparations
Brain
Therapeutics
Short-Term Memory
Semantics
Neuroimaging
Pharmacokinetics

Keywords

  • fMRI
  • rivastigmine
  • treatment
  • dementia
  • Alzheimer’s disease

Cite this

@article{cb6344bba0ff4584987c66f7983ddcf1,
title = "Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease",
abstract = "Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) indicate that the short and long term actions of ChEIs are dissimilar. fMRI studies of the ChEI rivastigmine have focused on its short term action. In this exploratory study the effect of prolonged (20 weeks) rivastigmine treatment on regional brain activity was measured with fMRI in patients with mild AD. Eleven patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. There was an increase in task-related brain activity after treatment with activations more like those of normal healthy elderly. Behaviorally, however, there were no significant differences between baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Variable patient response and drug dynamic/kinetic factors in small patient groups will inevitably bias (either way) the effect size of any relevant drug related changes in activation. Future studies should take drug response into account to provide more insight into the benefits of ChEI drugs at the individual level.",
keywords = "fMRI, rivastigmine, treatment, dementia, Alzheimer’s disease",
author = "McGeown, {William J} and Shanks, {Michael F} and Annalena Venneri",
year = "2008",
month = "4",
doi = "10.2147/NDT.S2461",
language = "English",
volume = "4",
pages = "465--476",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
number = "2",

}

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease. / McGeown, William J; Shanks, Michael F; Venneri, Annalena.

In: Neuropsychiatric Disease and Treatment, Vol. 4, No. 2, 04.2008, p. 465-476.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease

AU - McGeown, William J

AU - Shanks, Michael F

AU - Venneri, Annalena

PY - 2008/4

Y1 - 2008/4

N2 - Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) indicate that the short and long term actions of ChEIs are dissimilar. fMRI studies of the ChEI rivastigmine have focused on its short term action. In this exploratory study the effect of prolonged (20 weeks) rivastigmine treatment on regional brain activity was measured with fMRI in patients with mild AD. Eleven patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. There was an increase in task-related brain activity after treatment with activations more like those of normal healthy elderly. Behaviorally, however, there were no significant differences between baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Variable patient response and drug dynamic/kinetic factors in small patient groups will inevitably bias (either way) the effect size of any relevant drug related changes in activation. Future studies should take drug response into account to provide more insight into the benefits of ChEI drugs at the individual level.

AB - Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) indicate that the short and long term actions of ChEIs are dissimilar. fMRI studies of the ChEI rivastigmine have focused on its short term action. In this exploratory study the effect of prolonged (20 weeks) rivastigmine treatment on regional brain activity was measured with fMRI in patients with mild AD. Eleven patients with probable AD and nine age-matched controls were assessed with a Pyramids and Palm Trees semantic association and an n-back working memory fMRI paradigm. In the patient group only, the assessment was repeated after 20 weeks of treatment. There was an increase in task-related brain activity after treatment with activations more like those of normal healthy elderly. Behaviorally, however, there were no significant differences between baseline and retest scores, with a range of performance probably reflecting variation in drug efficacy across patients. Variable patient response and drug dynamic/kinetic factors in small patient groups will inevitably bias (either way) the effect size of any relevant drug related changes in activation. Future studies should take drug response into account to provide more insight into the benefits of ChEI drugs at the individual level.

KW - fMRI

KW - rivastigmine

KW - treatment

KW - dementia

KW - Alzheimer’s disease

UR - http://www.dovepress.com/prolonged-cholinergic-enrichment-influences-regional-cortical-activati-peer-reviewed-article-NDT

U2 - 10.2147/NDT.S2461

DO - 10.2147/NDT.S2461

M3 - Article

VL - 4

SP - 465

EP - 476

JO - Neuropsychiatric Disease and Treatment

T2 - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

IS - 2

ER -